Altathera Pharmaceuticals is a precision medicine company based in Chicago, IL, dedicated to revolutionizing therapy delivery, enhancing patient care, and reducing healthcare expenses.
With a focus on individualized treatment, Altathera aims to bridge the gap between scientific innovation and clinical decision-making in cardiovascular drug therapy, ultimately improving patient outcomes. Their first product, Sotalol IV, is a groundbreaking formulation of a widely used antiarrhythmic drug that shortens hospital stays by converting inpatient procedures to outpatient procedures.
Generated from the website